Last updated on November 2019

Respiratory Syncytial Virus (RSV) Infection

Brief description of study

If you are age 65 or older and in good or stable health, you may qualify for an RSV (Respiratory Syncytial Virus) Vaccine study at Advanced Clinical Research.


Clinical Study Identifier: TX228551

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.